- Study Suggests AI Software May Offer Standalone Value for X-Ray Detection of Pediatric Fractureson April 9, 2025 at 9:46 pm
Artificial intelligence (AI) software demonstrated a 92 percent sensitivity for detecting fractures in a study involving over 1,600 X-rays from a tertiary pediatric emergency department.
- Study Suggests AI Software May Offer Standalone Value for X-Ray Detection of Pediatric Fractureson April 9, 2025 at 9:46 pm
Artificial intelligence (AI) software demonstrated a 92 percent sensitivity for detecting fractures in a study involving over 1,600 X-rays from a tertiary pediatric emergency department.
- Teladoc Health Launches New Cardiometabolic Health Programby Marissa Plescia on April 9, 2025 at 9:37 pm
Through Teladoc’s new cardiometabolic health program, patients gain access to the BetterSleep app, a registered dietitian, health coaches, at-home testing and more. The post Teladoc Health Launches New Cardiometabolic Health Program appeared first on MedCity News.
- How One Health System Is Embedding Diabetic Retinopathy Screening Into Primary Careby Katie Adams on April 9, 2025 at 9:30 pm
OhioHealth is scaling an AI solution that it began piloting in 2022: Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy during primary care visits. The post How One Health System Is Embedding Diabetic Retinopathy Screening Into Primary Care appeared first on MedCity News.
- Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancerby Frank Vinluan on April 9, 2025 at 7:34 pm
Solu Therapeutics’ platform technology, which was licensed from GSK, pairs a small molecule with an antibody to address elusive disease targets. Cancer is Solu’s initial focus, but the startup is also exploring applications of its platform to immunology. The post Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer appeared first on MedCity News.
